Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6 | WKN:A3CSSU) is pleased to announce that scientists at its wholly-owned subsidiary Awakened...
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada The post Field Trip facilitates beneficial...
Core One Labs Inc. (CSE: COOL | OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) announces that it has initiated rollout of its commercial sales strategy...
With magic mushrooms seemingly being used more widely than ever, it's high time we look at the ancient history of psychotropic fungi.
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program The post Filament administers psilocybin...
The article Cathie Wood’s ARK Invest Releases Psychedelic Research Report was originally published on Microdose. We’ve been reporting on controversial...
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. The newest...
Company set to introduce psychedelic product catalogue showcasing in-house EU-GMP manufacturing expertise Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF)...